NUVL
Nuvalent, Inc.
NASDAQ · Healthcare · Biotechnology · US
$123.96
+0.00%0
Insider buys (3m)
9
Insider sells (3m)
-$14.0M
Net value (3m)
+13.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 15, 2026 | Lane Benjamin · officer: See Remarks | A-Award | 7,120 | $0.00 |
| Jul 15, 2026 | Turner Christopher Durant · officer: Chief Medical Officer | A-Award | 14,350 | $0.00 |
| Jul 15, 2026 | Noci Darlene · officer: Chief Development Officer | A-Award | 14,350 | $0.00 |
| Jul 15, 2026 | Miller Deborah Ann · officer: Chief Legal Officer | A-Award | 14,350 | $0.00 |
| Jul 15, 2026 | Balcom Alexandra · officer: Chief Financial Officer | A-Award | 14,350 | $0.00 |
| Jul 15, 2026 | Porter James Richard · director, officer: President and CEO | A-Award | 40,025 | $0.00 |
| Jul 15, 2026 | Pelish Henry E. · officer: Chief Scientific Officer | A-Award | 14,350 | $0.00 |
| Jul 10, 2026 | Pelish Henry E. · officer: Chief Scientific Officer | Sale | 2,111 | $124 |
| Jul 8, 2026 | Porter James Richard · director, officer: President and CEO | Sale | 30,000 | $124 |
| Jul 8, 2026 | Porter James Richard · director, officer: President and CEO | M-Exempt | 30,000 | $19 |
| Jul 6, 2026 | Balcom Alexandra · officer: Chief Financial Officer | M-Exempt | 5,384 | $6.89 |
| Jul 6, 2026 | Noci Darlene · officer: Chief Development Officer | M-Exempt | 13,854 | $72 |
| Jul 6, 2026 | Noci Darlene · officer: Chief Development Officer | M-Exempt | 9,146 | $19 |
| Jul 6, 2026 | Balcom Alexandra · officer: Chief Financial Officer | M-Exempt | 6,046 | $19 |
| Jul 6, 2026 | Balcom Alexandra · officer: Chief Financial Officer | Sale | 11,430 | $124 |
| Jul 6, 2026 | Noci Darlene · officer: Chief Development Officer | Sale | 23,000 | $124 |
| Jul 1, 2026 | Noci Darlene · officer: Chief Development Officer | M-Exempt | 5,500 | $28 |
| Jul 1, 2026 | Noci Darlene · officer: Chief Development Officer | Sale | 5,500 | $124 |
| Jun 18, 2026 | Flynn James E · director, 10 percent owner, other: Director by Deputization | A-Award | 3,444 | $0.00 |
| Jun 18, 2026 | Wheeler Cameron · director | A-Award | 3,444 | $0.00 |
| Jun 18, 2026 | Srivastava Sapna · director | A-Award | 3,444 | $0.00 |
| Jun 18, 2026 | Oliger Christy J. · director | A-Award | 3,444 | $0.00 |
| Jun 18, 2026 | Meyers Michael L. · director | A-Award | 3,444 | $0.00 |
| Jun 18, 2026 | Squarer Ron · director | A-Award | 3,444 | $0.00 |
| Jun 18, 2026 | Bogle Grant C. · director | A-Award | 3,444 | $0.00 |
| Jun 18, 2026 | Protopapas Anna · director | A-Award | 3,444 | $0.00 |
| Jun 11, 2026 | Noci Darlene · officer: Chief Development Officer | M-Exempt | 9,315 | $19 |
| Jun 11, 2026 | Noci Darlene · officer: Chief Development Officer | M-Exempt | 685 | $6.89 |
| Jun 11, 2026 | Noci Darlene · officer: Chief Development Officer | Sale | 20,000 | $123 |
| Jun 11, 2026 | Noci Darlene · officer: Chief Development Officer | M-Exempt | 10,000 | $1.08 |
Institutional positioning
13F filings over the trailing two quarters
New 165Increased 201Reduced 140Sold out 74
| Filer | Action | Shares | Filed |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. | Unchanged | 17,248,450 | Aug 14, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Unchanged | 17,248,450 | May 15, 2026 |
| FMR LLC | Reduced | 9,274,959 | May 15, 2026 |
| Paradigm Biocapital Advisors LP | Increased | 5,924,433 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 5,585,619 | Aug 7, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | Increased | 5,324,433 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 4,824,785 | May 13, 2026 |
| HBK INVESTMENTS L P | New Position | 3,483,100 | Aug 14, 2026 |
| JPMORGAN CHASE & CO | Increased | 3,088,349 | May 13, 2026 |
| FIL Ltd | Increased | 2,946,506 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 2,589,282 | Aug 13, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Increased | 2,534,145 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 2,500,907 | May 8, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 2,470,491 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,459,118 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 15, 2026